Post-Licensure Observational Study of the Long-term Effectiveness of ZOSTAVAX™
Post-Licensure Observational Study of the Long-term Effectiveness of ZOSTAVAX™
This study will describe the impact of vaccination with ZOSTAVAX™ on the epidemiology of herpes zoster (HZ) in a cohort of vaccinated participants 50 years or age or older, compared to a cohort of unvaccinated participants.
Inclusion Criteria:
Exclusion Criteria: